Introduction
Pulmonary arterial hypertension (PAH) is characterised by pulmonary arterial vasospasm, intimal hyperplasia, vascular smooth muscle cell (VSMC) proliferation, in situ thrombosis, and vascular remodeling, which may ultimately lead to heart failure and even death [1] [2] [3] . Despite significant advances in mechanistic research and drug development for PAH over the last several decades, treatment for PAH is limited and exhibits poor efficacy. Although the etiology and pathogenesis of PAH remain highly complex and unclear [4] , most patients eventually die from refractory right heart failure. Gaine, et al. [1] reported that pulmonary artery pressure has little effect on the prognosis of patients with PAH. Chin, et al. [5] revealed that the right ventricular function under a high-pressure load determined PAH severity and patient survival. Based on the above theory, it is critical to find new and practical evaluation and treatment methods to intervene in the occurrence and development of subclinical right heart failure before right heart failure occurs. Therefore, clarifying the mechanism of right ventricular remodeling in PAH may be conducive to promoting the development of anti-reconstruction treatment.
Hepatocyte growth factor (HGF), a pleiotropic growth factor, has been shown to exhibit mitogenic, morphogenic and antiapoptotic activities in various cell types [6] . HGF acts as a safe and effective organotrophic factor for protection from injury and ischemia of the heart and liver [7, 8] . Sakamaki et al. [9] found that in a mouse lung resection model, residual lung, liver and kidney tissue exhibited significantly increased HGF/c-met levels after the operation. This increase in HGF/c-met levels occurred before compensatory DNA synthesis in the epithelial cells. Hiramine, et al. [10] found that intravenous delivery of recombinant human HGF may lead to the amelioration of pulmonary hemodynamics and prolonged survival of animals suffering from severe monocrotaline-induced pulmonary arterial hypertension. In addition, HGF is involved in the adhesion of stem cells to the microenvironment [28] . Therefore, we hypothesise that the application of HGF genetically modified mesenchymal stem cells (MSCs) could provide a significant beneficial effect, increasing the efficacy of the PAH treatment. In this study, we investigated whether HGF expression following transplantation of genetically modified MSCs could offer a therapeutic benefit to pulmonary hypertensive rats, and investigated the mechanisms underlying the effects of this treatment method.
Experimental Procedures

Animals
Adult Male Sprague-Dawley (SD) rats matched for weight (250-300 g) were obtained from the experimental animal department of Chinese PLA General Hospital (Beijing, China). Monocrotaline (MCT) (Sigma Chemical Co. USA), 60 mg/kg, was intraperitoneally injected. Three weeks later, they were randomly divided into the following groups: the PAH group (n=10), MSC group (transplantation of 5×10 6 MSCs, n=10), and HGF group (transplantation of 5×10 6 MSCs transfected with Ad-HGF into the jugular veins, n=19; nine of these animals were used to validate HGF expression). Another three weeks later, all rats were sacrificed. The study also contained 10 normal rats (not treated with MCT) as a control group. The number of animals was kept to the minimum required. Sacrificed rats or rats who died prematurely were replaced with new experimental rats to maintain the animal numbers according to the original experiment design. This animal study was approved by the Institutional Animal Care Committee of Chinese PLA General Hospital (approval No. 20101201). The investigation conformed to the "Guidelines for the Care and Use of Laboratory Animals" published by the National Academy Press (NIH Publication No. 85-23, revised 1985).
Preparation of mesenchymal stem cells
Bone marrow cells were aspirated from the femur and tibia of 80-100 g SD rats. The cell suspension was loaded on a 20 to 60% Percoll gradient (Sigma Chemical Co., USA) and centrifuged at 900 g for 30 min. The top two-thirds of the total volume was transferred into a tube and washed with PBS (Sigma Chemical Co., USA) to remove the Percoll. Then, the cells were cultured in Dulbecco's modified Eagle's medium (Gibco Co., USA) containing 10% fetal bovine serum (Hyclone Laboratory, USA) and antibiotics. After 24 hours, nonadherent debris was removed and adherent cells were cultured. Flow cytometry assays for the cell surface antigens CD29, CD34, CD44, and CD45 on rat MSCs were performed as described previously [11, 12] . The cells were suspended with 0.25% Trypsin and 1 mM EDTA (Sigma Chemical Co., USA) and 5×10 5 cells were washed in 3 ml of PBS (Sigma Chemical Co., USA). After centrifugation, the pellet was suspended in 200 µl of the primary antibody solutions for 30 minutes at room temperature in the dark. The analysis was then performed with a flow cytometer (Beckton Dickinson, USA). Cells prepared in this way were characterised in our previous publication [13] .
Adenoviral vectors and gene transfection and expression
The HGF construct (Ad-HGF) was made by the Chinese Academy of Military Medical Sciences and is a replication-deficient recombinant adenovirus vector carrying human HGF [14, 15] . The mesenchymal stem cells were infected with the recombinant replicationdefective adenovirus at different m.o.i. ranging from 0 to 200, and the infection efficiency was determined by flow cytometry. An m.o.i. of 150 was found to be ideal for high efficiency and low toxicity infection of MSCs [16] . Therefore, the MSCs were transfected with Ad-HGF at an m.o.i. of 150 in subsequent experiments.
Hemodynamic measurements and measurement of right ventricle hypertrophy
PAH rats were anesthetised with Chloral Hydrate (2.5 mg/kg; Chinese PLA General Hospital) three weeks after transplantation of MSCs. The right jugular veins were cannulated with a 2% (v/v) heparin-saline filled polyethylene catheter (PE50; 0.97 mm OD, 0.58 mm ID) connected to a pressure transducer (Instrument Plant of Chengdu, Chengdu, China) to measure pulmonary arterial systolic pressure (PASP), mean pulmonary arterial pressure (mPAP) and right ventricular systolic pressure (RVSP). Data were recorded using the polygraph system (RM-6240, Instrument Plant of Chengdu). After conducting hemodynamic measurements, the rats were sacrificed. The weights of the right ventricle (RV) and left ventricle (LV) with the septum were measured to evaluate RV hypertrophy.
Detection of gene and protein expression
Total RNA was extracted from right heart ventricle tissue using Trizol reagent (Invitrogen, CA). Reverse transcription was performed using SuperScript III (Invitrogen, CA). PCR was performed using the iCycler™ Thermal Cycler (Bio-Rad Co., USA) and the following primers: hHGF forward primer, 5'-ATGATGTCCACGGAAGAGGAGA-3', reverse primer, 5'-CACTCGTAATAGGCCATCATAGTTGA-3'; GAPDH forward primer, 5'-CCATCACTGCCACTCAGAAGAC-3', reverse primer, 5'-TCATACTTGGCAGGTTTCTCCA-3'. In addition, total protein was extracted from the samples using RIPA Lysis Buffer (Applygen Gene Technology Corp, Beijing, China), and the amount of protein was measured using the Bicinchoninic acid method. Immunoblotting was performed using antibodies against HGF (1:200; ab24865, Abcam, U.K.). Protein detection was performed using the ECL kit (Applygen Gene Technology Corp). All the experiments described above were conducted in accordance with the manufacturer's instructions.
Light microscopy specimen preparation and morphological observation
Hearts were collected and fixed in 2.5% (v/v) glutaraldehyde-polyoxymethylene solution immediately after euthanasia. The tissue samples were dehydrated and embedded in paraffin wax. Serial paraffin sections (4 um) were obtained and kept at 37°C for more than 12 h. The sections were immersed in three consecutive washes of xylol for 5 min to remove paraffin, and then hydrated with five consecutive washes of descending alcohol contents: 100, 95, 80, 70, 50% and finally deionised water. The histological paraffin sections were then stained with HE. Changes in the organisational structure were visualised using a light microscope. Three fields per section and three sections per rat were analysed. Transverse sections of the heart just inferior to the mitral valve leaflet were evaluated for RV-free wall and left ventricle (LV)-free wall thickness using the Microanalyzer (Olympus BX-45, Tokyo, Japan). The calculated RV/LV ratio was considered an index of RV hypertrophy.
Transmission electron microscopy
For transmission electron microscopy (TEM), the heart samples were cut into pieces (1 mm 3 ) and fixed in 2.5% (v/v) glutaraldehyde-polyoxymethylene solution for 6-8 h at 4°C. The samples were washed and post fixed in 2% OsO 4 for 1 h at 4°C. The tissue was dehydrated through ascending grades of ethanol and embedded in araldite CY212. Ultra thin sections (60-70 nm) were cut and stained with uranyl acetate and alkaline lead citrate. Sections were visualised under a JEM 100CX transmission electron microscope.
Examination through immunofluorescence microscopy
Blocks (1×0.4 cm) were taken quickly from the RV-free wall and frozen in liquid nitrogen. Cryosections with a thickness of 8 mm were mounted on glass slides, immersed in absolute acetone for 10 min, rinsed three times in PBS for 5 min each, and then incubated with 1% goat serum albumin (ZSGB-Bio, China) in PBS for 40 min at room temperature to reduce non-specific binding. The sections were then incubated for 1 h at 37°C in an incubator with the primary antibodies at a 1:200 dilution. The primary antibodies were mouse antiCx43 monoclonal antibody (Santa Cruz Biotechnology, Inc., CA, USA) and sheep anti-Cx40 polyclonal antibody (Abcam, Cambridge, UK). For a negative control group, this incubation with the primary antibodies was omitted. After three more rinses in PBS, the sections were incubated for 30 min at 37°C with the secondary antibodies at a 1:200 dilution in BSA-PBS. Goat antimouse IgG-FITC and rabbit anti-sheep IgG-FITC (Santa Cruz Biotechnology, Inc., CA, USA) were used as the secondary antibodies. After washing, the labeled samples were examined using a confocal microscope (Leica Microsystems GmbH, Germany). In addition to the distribution of connexin 43 (Cx43) and Cx40, the intensities of the Cx43 and Cx40 signals were measured using imagePro Plus software (Media Cybernetics). All data were obtained from 10 rats of each group: 10 controls, 10 PAH rats, 10 MSC rats, and 10 MSC-HGF rats. For the MSC-HGF group, three randomly selected fields from longitudinally sectioned tissue were analysed for each rat.
Statistical analysis
All data are expressed as the mean ± SD. Statistical comparisons among the four groups were carried out using a one-way analysis of variance (ANOVA) followed by an LSD or SNK-q protected least significant difference test between any two groups. SPSS 16.0 software was used for all analyses. Values of P<0.05 were considered to be statistically significant.
Results
Engraftment of MSCs into the heart and expression of exogenous human HGF in vivo
Rats were sacrificed 3 days (n=3), 7 days (n=3) and 21 days (n=3) after the transplantation of MSCs infected with Ad-HGF to determine whether the myocardial tissue expresses HGF. PCR and western blot demonstrated HGF gene and protein expression in the heart tissue at 3 days and 7 days after the transplantation. However, 21 days after transplantation, the HGF protein was detected but not HGF gene expression (Figure 1 ). These results demonstrate the successful introduction and expression of the HGF gene in myocardial tissue.
Hemodynamic index measurements
To determine the effect of HGF and MSC on the hemodynamic index, rats with PAH were catheterised, and mPAP, PASP, RVSP and RVSP to carotid arterial SBP (representing aortic systolic pressure) were examined three weeks after treatment (Figure 2 
RV/LV weight and thickness ratios
The RV/LV weight ratios in the control, PAH, MSC, and MSC-HGF groups were 23.94±5.87%, 36.86±8.25%, 33.79±6.54%, and 29.61±5.62%, respectively ( Figure 3A ). Significant differences were observed between the control, PAH and MSC groups (P<0.05), as well as between the PAH and MSC-HGF groups (P<0.05). The RV/LV thickness ratios for the control, PAH, MSC, and MSC-HGF groups were 2.25± 3.73%, 79.52±9.25%, 69.98±3.93%, and 58.99±7.2%, respectively ( Figure 3B ). The differences between all pairs of groups were statistically significant (P<0.05). That is, although the RV/LV thickness ratio of the MSC-HGF group was significantly lower than that of the PAH group, it was still higher than that in the control group.
Changes in morphological characteristics observed by light microscopy
Compared with the control group, the PAH group exhibited distinct myocardial cell hypertrophy. The myocardial nuclei in this group were increased in both number and size. Parts of the myocardial fibers were loose, and the interstitial substance was fibrotic. In the MSC and MSC-HGF groups, normal cardiac myocytes and cell nuclei were recovered, and interstitial fibrosis was improved. The myocardial nuclear counts of the normal control group, PAH group, MSC group and HGF-MSC group were 609.2±181.6, 1459.7±244.5, 1215.2±274.6, and 1086.4±219.1 nuclei/field, respectively (P<0.05). This decrease in nuclear counts was more pronounced in the MSC-HGF group Than the MSC group (Figure 4 ). In addition, Figure 5 shows the histomorphological changes in the lung tissues of these four groups. The PAH group exhibited vascular smooth muscle cell proliferation and collagen accumulation leading to vascular medial thickness and marked pulmonary arterial stenosis. In contrast, vascular smooth muscle cell proliferation and the extracellular matrix were decreased in the MSC and MSC-HGF groups.
Ultrastructural changes observed by electron microscopy
In the control group, myocardial fibers were well ordered and in close proximity, and mitochondria were normal. A larger number of gap junctions were clearly observed under the electron microscope.
In the PAH group, some myocardial fibers were disorganised and loosened, and some even exhibited a scattered distribution. The endoplasmic reticula were dilated and the mitochondria were swelled; gap junctions were disorganised and fewer in number than in the other three groups. The myocardial cells in the MSC and MSC-HGF groups were improved compared with the PAH group. Especially in the MSC-HGF group, muscle fibers were closely arranged, gap junctions were relatively regular and the number of gap junctions was increased compared with the PAH group. Additionally, no fibrosis was found in the control group, while part of the interstitial substance appeared as distinct fibrosis in the PAH group. The MSC and MSC-HGF groups exhibited less fibrosis than the PAH group (Figure 6 ).
Cx43 and Cx40 expression in the RV myocytes
To explore the mechanisms of action of HGF-MSCs in PAH treatment, we studied connexin expression. Most of the Cx43 staining was concentrated at the cell termini, which are perpendicular to the long axis of the myocardium. The PAH group had significantly fewer gap junctions than the other three groups. Figure 7) . However, all of the Cx40 staining was concentrated at side-side cell junction sites, which are parallel to the long axis of the myocardium. The PAH group had significantly fewer gap junctions than the other three groups. Although the PAH group has the smallest area of Cx40 distribution (P=0.003), no significant differences were observed between the PAH group (22.56±6. myocardial fibers were well ordered and the mitochondria were normal, no fibrosis was observed and the gap junctions were obvious and frequent. In the PAH group (B; left, 25,000x magnification; right, 40,000x magnification), some of the myocardial fibers were disorganised and loosened, the endoplasmic reticula were dilated, and the mitochondria were swelled; part of the interstitial substance appeared as distinct fibrosis; and the gap junctions were disordered and rare. In the MSC-HGF group (D; left, 12,000x magnification; right, 50,000x magnification), most myocardial fibers were arranged in order, interstitial fibrosis was improved, and gap junctions were increased in intercalated disks. The morphology of the MSC group as observed by electron microscopy was intermediate between the PAH and MSC-HGF groups. Arrows: gap junctions. 
Discussion
The major finding of this study was that the transplantation of HGF genetically modified MSCs in MCT-induced PAH rats improves pulmonary hemodynamics significantly better than a single MSC treatment. One reason for this improvement is that gap junctions may be involved in the process of cardiac remodeling. Therefore, therapy with HGF genetically modified MSCs may offer an attractive alternative method for treatment of PAH.
Stem cell therapy has been widely applied to cardiovascular diseases, effectively improving cardiac function. Studies have shown that bone marrow mesenchymal stem cells (BMSCs) exert potent effects on cardiomyocytes through mechanisms such as cytokine secretion, apoptosis inhibition, attenuation of inflammation, and myoangiogenic differentiation [17] [18] [19] [20] . Umar et al. [21] found that the application of MSCs from donor rats with PAH reduces RV pressure overload, RV dysfunction, and lung pathology in recipient rats with PAH. Molina, et al. [22, 23] found that heart failure can be treated by MSCs, leading to an improvement in hemodynamic performance, systemic inflammation, apoptosis, and left ventricular reverse remodeling. In this study, we found that the status of MCT-induced rats improved after MSC treatment, reducing RV pressure overload and ameliorating RV dysfunction. Taken together, these results show that the treatment of pulmonary hypertension with stem cells is effective.
As reported by Duncan et al., combining cell therapy with genetic engineering may enhance the regenerative function of endothelial cells and myocardial cells and provide additional benefits that may overcome many of the limitations of cell or gene therapy alone [24] . Some studies have shown that gene transfer of endothelial nitric oxide synthase (eNOS) or a variety of angiogenic factors such as vascular endothelial growth factor or angiopoietin-1 can prevent endothelial cell apoptosis and induce angiogenesis of MCTinduced pulmonary hypertension in rats [25, 26] . HGF has been shown to exert mitogenic, morphogenic and antiapoptotic activities in various cell types [6] . A variety of studies have shown that HGF improved pulmonary hemodynamic parameters and the recovery from right ventricular and pulmonary remodeling in PAH models [ 10, 27] . Furthermore, HGF is involved in the adhesion of stem cells to the microenvironment [28] . Therefore, we injected MSCs modified with human HGF into PAH rats. We found HGF gene expression in the heart tissue of the MSC-HGF group at 3 days and 7 days after the transplantation. The MSC-HGF group had lower mPAP, PASP, RVSP and RVSP to carotid arterial SBP than the PAH and MSC groups. The RV/LV weight and thickness ratios were significantly reduced in the MSC-HGF group compared with the PAH group. Light microscopy revealed that cardiac myocytes and cell nuclei were recovered and interstitial fibrosis was improved. Guo et al. [29] inferred that HGF may act as a treatment for PAH based on mechanisms such as endothelial repair, progenitor cell mobilisation, reversal of vascular remodeling, and improvement of angiogenesis.
One of the most important findings in the present study was the remarkable downregulation of Cx43 following MCT administration. The main function of gap junctions is to efficiently transmit contraction signals, allowing the heart muscle cells to contract in tandem. In addition, gap junctions also play a role in cell metabolism, proliferation, and differentiation. Tissue damage will result in a change in the gap junction protein distribution and quantity [30] . Teunissen et al. [31] reported that close relationships exist between disease progression and levels of the gap junction protein Cx43 levels in patients with various types of cardiac hypertrophy. In this study, we found that the Cx43 amount, area, and integrated optical density was significantly lower in the PAH group than in the other three groups. MSC or MSC-HGF treatment led to an obvious increase in Cx43, with the most significant effect observed for MSC-HGF. In addition to Cx43, the main subtypes in the heart are Cx45, Cx40 and Cx37 [32] . Accordingly, we also monitored Cx45, Cx40 and Cx37 expression in the RV myocytes by immunofluorescence. However, we only detected the expression of Cx40. Interestingly, there is a significant difference between the distribution of Cx40 in the myocardial tissue and the distribution of Cx43. The Cx40 staining was concentrated at sites of side-side cell junctions, which are parallel to the long axis of the myocardium. We also found that the gap junction number, area, and integrated optical density were significantly lower in the PAH group than in the other three groups and that MSC-HGF treatment had a greater effect on these parameters than MSC treatment. Some studies have also shown that Cx43 expression was substantially down-regulated by hypertrophy resulting from PAH in rats [33] [34] [35] , in accordance with our results. Uzzaman, et al. [33] interpreted the altered Cx43 gap junction distribution as a component of the extensive hypertrophic remodeling that occurs in response to pressure overload (pulmonary hypertension) rather than a direct toxic effect of MCT treatment. Therefore, it is reasonable to speculate that disorder in the distribution of gap junctions is likely to directly or indirectly lead to right ventricular hypertrophy.
This study has some limitations. First, although MSC and HGF-MSC treatment achieved more satisfactory results, these findings are still not predictive of the responses to therapy in PAH patients. We cannot predict the efficacy or side effects of this treatment. Secondly, there are limitations involved in using MCT-injected rats as models of human PAH. Many interventions improve pulmonary hypertension in this model, including many that do not work in human PAH [36] . However, the MCTinduced PAH model has been validated and is widely accepted for PAH-related studies because it definitely induces pulmonary endothelial injury, interstitial fibrosis, and the proliferation of muscular intimal cells [37] . Altered Cx43 gap junction distribution is interpreted as a component of the extensive hypertrophic remodeling that occurs in response to pressure overload rather than as a direct toxic effect of MCT treatment [33] . Third, despite the significant effect of MSC-HGF injection, HGF is not continuously expressed throughout the course of treatment (HGF is only detected by PCR at 3 days and 7 days after injection). Therefore, further study is required to determine how to obtain stable, continuous and efficient expression of HGF modified MSCs.
In summary, this study suggests that MCT-induced rat PAH can be treated and improved by HGF modified MSCs and that this improvement may occur via connexin remodeling mechanisms. Therefore, transplantation of HGF-MSCs may be a promising therapy for PAH. More importantly, connexins may become targets for the treatment of pulmonary hypertension.
